Download presentation
Presentation is loading. Please wait.
Published byHengki Cahyadi Modified over 6 years ago
3
Learning Objectives
4
Classification of VTE
5
Goals of VTE Treatment
6
Risk of VTE Recurrence
7
Factors That Predict High Risk of Recurrence
8
NOACs VTE Acute Treatment Trials
9
NOACs VTE Extended Treatment Trials
10
Duration of VTE Treatment
11
Extended Therapy for Unprovoked VTE
12
Bleeding Risk Factors
13
Extended Therapy for Provoked VTE
14
When to Stop Extended Therapy
15
Meta-analysis of VTE Studies Safety Outcomes Favor NOACs vs VKA
16
VTE With Persistent Risk Factors
17
Aspirin VTE Extended Treatment
18
VTE Extended Treatment Relative Risk-Benefit of NOAC vs Aspirin
19
Place of Aspirin in VTE Management
20
Vienna Prediction Model
21
NOACs Renal Clearance
22
Hokusai-VTE Trial Dose Adjustment
23
NOACs Bleeding Management
24
Abbreviations
25
References
26
References (cont)
27
References (cont)
28
References (cont)
29
References (cont)
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.